Clinical activity and safety from a phase II study (FIR) of MPDL3280A (anti-PDL1) in PD-L1-selected patients with non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Spigel, D. R.; Chaft, J. E.; Gettinger, S. N.; Chao, B. H.; Dirix, L. Y.; Schmid, P.; Chow, L. Q. M.; Chappey, C.; Kowanetz, M.; Sandler, A.; Funke, R. P.; Rizvi, N. A. |
| Abstract Title: | Clinical activity and safety from a phase II study (FIR) of MPDL3280A (anti-PDL1) in PD-L1-selected patients with non-small cell lung cancer (NSCLC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901741 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2015.33.15_suppl.8028 |
| Notes: | Meeting Abstract: 8028 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work